- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
195
Companies with a Value score of at least 3, ordered by Value score
195 companies
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPNZ
CHF 64.80
7D
-3.1%
1Y
-15.3%
Sanofi
Market Cap: €96.7b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
0O59
€79.50
7D
0.08%
1Y
-22.5%
Sanofi
Market Cap: €96.7b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SANP
€79.76
7D
0.5%
1Y
-22.0%
Hikma Pharmaceuticals
Market Cap: UK£3.6b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£16.13
7D
-0.9%
1Y
-13.6%
Regeneron Pharmaceuticals
Market Cap: US$58.9b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
0R2M
US$574.98
7D
-2.1%
1Y
-44.3%
Hikma Pharmaceuticals
Market Cap: UK£3.6b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIKL
UK£16.17
7D
-0.3%
1Y
-13.5%
Merck
Market Cap: US$199.7b
Operates as a healthcare company worldwide.
0QAH
US$79.69
7D
-2.7%
1Y
-31.0%
Perrigo
Market Cap: US$2.9b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
0Y5E
US$21.42
7D
1.0%
1Y
-16.6%
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
0RGI
CHF 65.00
7D
-3.3%
1Y
-15.5%
Teva Pharmaceutical Industries
Market Cap: US$22.3b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
0LER
US$19.27
7D
3.1%
1Y
9.4%
Evolus
Market Cap: US$735.7m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
0K16
US$14.58
7D
0%
1Y
23.7%
Sarepta Therapeutics
Market Cap: US$1.8b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
0L35
US$18.03
7D
2.1%
1Y
-85.5%
Vetoquinol
Market Cap: €890.6m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
0O1O
€75.00
7D
-5.9%
1Y
-11.2%
Iovance Biotherapeutics
Market Cap: US$749.0m
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.
0JDK
US$2.06
7D
-11.2%
1Y
-77.8%
Novartis
Market Cap: CHF 189.4b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVNz
CHF 97.83
7D
1.4%
1Y
-1.5%
Halozyme Therapeutics
Market Cap: US$9.1b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
0J2O
US$75.78
7D
-0.4%
1Y
36.5%
Pharming Group
Market Cap: €877.0m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
0QCO
€1.28
7D
5.3%
1Y
84.4%
Viatris
Market Cap: US$11.2b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
0A5V
US$9.71
7D
-0.9%
1Y
-14.5%
Johnson & Johnson
Market Cap: US$425.3b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
0R34
US$176.64
7D
-0.4%
1Y
9.7%
Novartis
Market Cap: CHF 189.4b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
0QLR
CHF 97.83
7D
1.4%
1Y
-1.5%
ACADIA Pharmaceuticals
Market Cap: US$2.4b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
0A4W
US$18.62
7D
0%
1Y
9.3%
Geron
Market Cap: US$854.9m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
0IV3
US$1.35
7D
2.7%
1Y
-69.9%
Beximco Pharmaceuticals
Market Cap: UK£52.5b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXP
UK£0.47
7D
0%
1Y
102.2%
Pfizer
Market Cap: US$137.2b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
0Q1N
US$24.12
7D
-0.3%
1Y
-17.5%
Novo Nordisk
Market Cap: DKK 1.7t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
0QIU
DKK 373.08
7D
1.7%
1Y
-55.9%
Bayer
Market Cap: €27.1b
Operates as a life science company worldwide.
0P6S
€27.44
7D
0.8%
1Y
-4.9%
Haleon
Market Cap: UK£29.5b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLNL
UK£3.31
7D
-3.4%
1Y
-15.8%
HUTCHMED (China)
Market Cap: UK£2.0b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£2.30
7D
-9.4%
1Y
-11.9%
Amicus Therapeutics
Market Cap: US$2.5b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
0HF9
US$8.34
7D
3.6%
1Y
-24.2%
Vertex Pharmaceuticals
Market Cap: US$97.4b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
0QZU
US$379.00
7D
-3.5%
1Y
-17.7%
Oxford Biomedica
Market Cap: UK£699.5m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£5.82
7D
-1.0%
1Y
57.3%
Sanofi
Market Cap: US$96.7b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
0A2V
US$46.62
7D
-1.5%
1Y
-17.8%
Biogen
Market Cap: US$20.4b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
0R1B
US$137.11
7D
-6.2%
1Y
-28.1%
H. Lundbeck
Market Cap: DKK 43.4b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
0ABR
DKK 36.10
7D
2.6%
1Y
-5.5%
Emergent BioSolutions
Market Cap: US$436.4m
A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.
0IGA
US$8.10
7D
1.8%
1Y
35.9%
Johnson & Johnson
Market Cap: €425.3b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJD
€150.06
7D
1.0%
1Y
2.3%